# Nuclide record itm-11 (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/itm-11/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "itm-11" ;
  schema:name "177Lu-edotreotide"@en ;
  schema:description "A second lutetium radioligand for neuroendocrine tumours that beat the standard pill everolimus in a head-to-head trial and is awaiting an FDA decision."@en ;
  schema:url <https://nuclide.cc/drugs/itm-11/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03049189> ;
  nuclide:status "phase-3" ;
  nuclide:modality "Radioligand therapy (beta)" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/neuroendocrine/>, <https://nuclide.cc/indications/grade-3-net/> ;
  nuclide:technologies <https://nuclide.cc/technologies/prrt/>, <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:targets <https://nuclide.cc/targets/sstr2/> ;
  nuclide:companies <https://nuclide.cc/companies/itm/> ;
  nuclide:trials <https://nuclide.cc/trials/compete/>, <https://nuclide.cc/trials/nct04919226/> .